Cargando…
The Novel Anticancer Drug KRN5500 Interacts with, but is Hardly Transported by, Human P‐Glycoprotein
The interaction of the novel anticancer drug KRN5500, a spicamycin derivative, with human Pglycoprotein (P‐gp) was analyzed from the viewpoint of cellular pharmacokinetics, i.e. by means of [(3)H]azidopine photoaffinity labeling, cellular accumulation and transcellular transport experiments. In this...
Autores principales: | Takara, Kohji, Tanigawara, Yusuke, Komada, Fusao, Nishiguchi, Kohshi, Sakaeda, Toshiyuki, Okumura, Katsuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926333/ https://www.ncbi.nlm.nih.gov/pubmed/10761713 http://dx.doi.org/10.1111/j.1349-7006.2000.tb00938.x |
Ejemplares similares
-
Interaction of Docetaxel (“Taxotere”) with Human P‐Glycoprotein
por: Shirakawa, Katsuro, et al.
Publicado: (1999) -
Inhibitory Effects of a Cyclosporin Derivative, SDZ PSC 833, on Transport of Doxorubicin and Vinblastine via Human P‐Glycoprotein
por: Kusunoki, Nobuya, et al.
Publicado: (1998) -
Incorporation of the Anticancer Agent KRN5500 into Polymeric Micelles Diminishes the Pulmonary Toxicity
por: Mizumura, Yasuo, et al.
Publicado: (2002) -
Reduction of the Side Effects of an Antitumor Agent, KRN5500, by Incorporation of the Drug into Polymeric Micelles
por: Matsumura, Yasuhiro, et al.
Publicado: (1999) -
Spicamycin and KRN5500 Induce Apoptosis in Myeloid and Lymphoid Cell Lines with Down‐regulation of Bcl‐2 Expression and Modulation of Promyelocytic Leukemia Protein
por: Zhang, Wen Jie, et al.
Publicado: (2000)